Pharmaceutical Excipient Market to Reach USD 1,600.0 Million by 2034 at a 5.1% of CAGR

Future Market Insights (FMI) has released an updated analysis of the pharmaceutical excipient market, projecting steady growth over the next decade. The market is expected to be valued at US$ 972.9 million in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 5.1%, reaching a valuation of US$ 1.6 billion by 2034.

https://www.futuremarketinsigh....ts.com/reports/pharm

Joint Replacement Market to Hit USD 27 Billion by 2032 at a 4.3% of CAGR

The global joint replacement market is poised for substantial growth, with its valuation projected to rise from US$ 17.1 billion in 2021 to US$ 27 billion by 2032, according to a newly released analysis report by Future Market Insights. This expansion represents a compound annual growth rate (CAGR) of 4.3% from 2022 to 2032.

https://www.futuremarketinsigh....ts.com/reports/joint

Antacids Market Value Rise to Reach USD 11,194.8 Million by 2033 with a 4.9% of CAGR

The global antacids market is set to experience steady growth, with its valuation projected to rise from US$ 6,971.2 million in 2023 to US$ 11,194.8 million by 2033, according to a recent report by Future Market Insights. This represents a compound annual growth rate (CAGR) of 4.9% over the forecast period.

https://www.futuremarketinsigh....ts.com/reports/antac

Prurigo Nodularis Treatment Market to Reach USD 930.9 Million by 2033 with a 3.0% CAGR

The global prurigo nodularis treatment market is projected to grow steadily, with its valuation expected to rise from US$ 693.3 million in 2023 to US$ 930.9 million by 2033, according to a Future Market Insights report. This growth represents a compound annual growth rate (CAGR) of 3.0% over the forecast period.

https://www.futuremarketinsigh....ts.com/reports/pruri

Neurotrophic Keratitis Treatment Market to Double in Value, Reaching USD 10 Billion by 2033 at a 7.17% CAGR

The global neurotrophic keratitis treatment market is on a trajectory of substantial growth, with its valuation expected to rise from US$ 5 billion in 2023 to an impressive US$ 10 billion by 2033. This reflects a compound annual growth rate (CAGR) of 7.17% over the forecast period, according to Future Market Insights.

https://www.futuremarketinsigh....ts.com/reports/neuro